mirtazapine has been researched along with Erythremia in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Verma, S | 1 |
Cikurel, K | 1 |
Koralnik, IJ | 1 |
Morgello, S | 1 |
Cunningham-Rundles, C | 1 |
Weinstein, ZR | 1 |
Bergmann, C | 1 |
Simpson, DM | 1 |
Focosi, D | 1 |
Kast, RE | 1 |
Maggi, F | 1 |
Lauria, G | 1 |
Ceccherini-Nelli, L | 1 |
Petrini, M | 1 |
2 other studies available for mirtazapine and Erythremia
Article | Year |
---|---|
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.
Topics: Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Po | 2007 |
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middl | 2008 |